Incidence and efficacy of strategies for preventing hepatic encephalopathy following transjugular intrahepatic portosystemic shunt: A meta-analysis

Figure 7 The effectiveness and survival of drug intervention on hepatic encephalopathy after transjugular intrahepatic portosystemic shunt. A: The therapeutic effects of different drug interventions for preventing hepatic encephalopathy (HE) after transjugular intrahepatic portosystemic shunt; B: Drug prevention intervention for the treatment of overt HE; C: The impact of drug prevention interventions on survival. LM: Lactulose monoprophylaxis; RM: Rifaximin monoprophylaxis; LR: Lactulose and rifaximin; NM: No prophylactic medication.